Takahashi et al., 2011 - Google Patents
Prepulse inhibition of startle response: recent advances in human studies of psychiatric diseaseTakahashi et al., 2011
View HTML- Document ID
- 13928664006454542864
- Author
- Takahashi H
- Hashimoto R
- Iwase M
- Ishii R
- Kamio Y
- Takeda M
- Publication year
- Publication venue
- Clinical Psychopharmacology and Neuroscience
External Links
Snippet
Prepulse inhibition (PPI) is considered to be one of the most promising neurophysiological indexes for translational research in psychiatry. Impairment of PPI has been reported in several psychiatric diseases, particularly schizophrenia, where PPI is considered a …
- 230000006977 prepulse inhibition 0 title abstract description 234
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Takahashi et al. | Prepulse inhibition of startle response: recent advances in human studies of psychiatric disease | |
| Hardiman et al. | Amyotrophic lateral sclerosis | |
| Van Heeringen et al. | The neurobiology of suicide | |
| Han et al. | Gender differences in cognitive function of patients with chronic schizophrenia | |
| Lee et al. | A meta-analysis of neuropsychological functioning in first-episode bipolar disorders | |
| Ho et al. | Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow | |
| Kollins et al. | ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: implications for smoking and nicotine dependence | |
| Shaughnessy et al. | A narrative review of handgrip strength and cognitive functioning: bringing a new characteristic to muscle memory | |
| Simpson et al. | A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia | |
| Fatemi et al. | Expression of GABAA α2-, β1-and ɛ-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder | |
| Braff et al. | Advances in endophenotyping schizophrenia | |
| Min et al. | Low trait anxiety, high resilience, and their interaction as possible predictors for treatment response in patients with depression | |
| Surget et al. | Antidepressants recruit new neurons to improve stress response regulation | |
| Cancel et al. | Understanding the link between childhood trauma and schizophrenia: a systematic review of neuroimaging studies | |
| Schroeter et al. | Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders | |
| Miettunen et al. | The age of onset of schizophrenia spectrum disorders | |
| Bhattacharyya et al. | Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control | |
| Yang et al. | Serum oxytocin levels and an oxytocin receptor gene polymorphism (rs2254298) indicate social deficits in children and adolescents with autism spectrum disorders | |
| Zhang et al. | BACE1-dependent neuregulin-1 signaling: an implication for schizophrenia | |
| Bosia et al. | Improving cognition to increase treatment efficacy in schizophrenia: effects of metabolic syndrome on cognitive remediation's outcome | |
| Kang et al. | Reduced binding potential of GABA-A/benzodiazepine receptors in individuals at ultra-high risk for psychosis: an [18F]-fluoroflumazenil positron emission tomography study | |
| Francis et al. | Variants in adjacent oxytocin/vasopressin gene region and associations with ASD diagnosis and other autism related endophenotypes | |
| Schreiner et al. | Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11. 2 deletion syndrome | |
| Kurachi | Pathogenesis of schizophrenia: Part II. Temporo‐frontal two‐step hypothesis | |
| Nawaz et al. | Overview of schizophrenia research and treatment in Pakistan |